Status:
UNKNOWN
Detection of Anti-COVID-19 Antibody Levels in an Hospital Population
Lead Sponsor:
Istituto Clinico Humanitas
Conditions:
COVID-19
Eligibility:
All Genders
18-90 years
Brief Summary
COVID-19 (SARS-CoV-2) infection in health professionals represent a significant criticality both for the risk of spreading the disease and for the organizational aspects that follow. The objective of ...
Detailed Description
The Coronavirus identified in Wuhan, China, for the first time in late 2019 is a new viral strain that has never previously been identified in humans. It has been called SARS-CoV-2 and the respiratory...
Eligibility Criteria
Inclusion
- Age\> 18 years old
- work for the Humanitas Group (Rozzano / San Pio X, Humanitas Gavazzeni, Humanitas Mater Domini, Humanitas University, Humanitas Medical Care)
- Work activity in the Humanitas Group for at least 3 months among which, for example:
- Healthcare Staff (Doctors, Nurses, OSS) Technical Staff (Biologists, Radiology Technicians, Laboratory Technicians, etc.) PARC staff and Staff Staff Research Internship students of Hunimed Contract staff (e.g. transport and sanitation services)
- Signature of informed consent
- Compilation of the anamnestic questionnaire
Exclusion
- Subjects absent for any reason during the study period
Key Trial Info
Start Date :
May 4 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 30 2021
Estimated Enrollment :
6000 Patients enrolled
Trial Details
Trial ID
NCT04387929
Start Date
May 4 2020
End Date
May 30 2021
Last Update
May 15 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Humanitas Rozzano/San Pio X
Rozzano, Lombardy, Italy, 20089